The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 1st 2025
In clinical trials, the dihydroergotamine (DHE) nasal powder had favorable safety profiles and rapid pain relief in patients with migraine with or without aura.
New Diabetes Drug Combination Induces High Rates of Human Beta Cell Regeneration
February 20th 2020When combining a drug that is known to cause beta cells to proliferate with another drug that is already in widespread use in people with diabetes, it will cause the cells to proliferate at a rate of 5% to 6% per day, according to the study authors.
Read More
Politicians on both sides of the aisle have long been debating key issues in modern health care, including rising drug prices, access to care, and national addiction rates. Despite some agreement on which issues are most pressing, arguments persist in how to address them heading into the 2020 presidential election.
Read More
FDA Approves Topical Arthritis Pain Reliever for Nonprescription Use
February 18th 2020Diclofenac sodium topical gel was first approved by the FDA in 2007 as a prescription drug, and was indicated for the relief of osteoarthritis pain in joints responsive to topical treatment, particularly the joints of the hands, knees, and feet.
Read More
Hydrogel Platform Preserves Medicines, Chemicals for Future Use
February 17th 2020New on-demand approach could aid where the absence of pharmacies, physician offices, or basic refrigeration makes it difficult to access critical medicines, daily use chemicals, and other small-molecule compounds.
Read More
Study Supports Added Use of Tiotropium Bromide for Asthma
February 16th 2020Results from a new retrospective analysis have shown that patients prescribed tiotropium bromide (Spiriva Respimat) inhalation spray 1.25 mcg experienced fewer asthma-related exacerbations when the treatment was added to a combination inhaled corticosteroid and long-acting beta2 agonist (ICS + LABA), compared with patients who received an increased dose of ICS + LABA.
Read More
New Integrated HIV Curriculum Lays the Foundation for Future Pharmacy Students
February 15th 2020The scope of HIV/AIDS treatment in America has changed immensely in recent years across the pharmacy landscape. Roosevelt University's College of Pharmacy (RUCOP) is helping to highlight this shift in its updated HIV/AIDS care and training program.
Read More
Health Experts Concerned Coronavirus Could Lead to Drug Shortages
February 14th 2020Although the number of US cases is still low, experts are raising concerns that the US reliance on China for pharmaceutical ingredients could result in drug shortages as Chinese officials battle the outbreak.
Read More
Report: Reference Pricing Decreases Overall Spending, Increases Patient Cost Sharing
February 14th 2020A new economic analysis published in JAMA found that the implementation of reference pricing increased the percentage of prescriptions filled for the lower-priced drugs within each therapeutic class, while simultaneously increasing patient cost sharing and decreasing overall prices paid.
Read More